Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients
Clinical trial NCT00128843 · COMPLETED
Trial details
- NCT number
- NCT00128843
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2005-07-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.